The World of Health & Medicine News

Nestle USA to phase out use of synthetic food colors by mid-2026

Nestle USA to phase out use of synthetic food colors by mid-2026

Nestle USA said on Wednesday that it would fully eliminate synthetic food colors from its U.S. food and beverage portfolio by mid-2026.

The DiGiorno pizza maker said that the transition will be completed within the next 12 months, adding that more than 90% of its current categories already do not contain synthetic colors.

The move comes after Health Secretary Robert F. Kennedy Jr. rolled out plans to remove synthetic food dyes from the U.S. food supply to address health conditions such as ADHD, obesity and diabetes.

Nestle USA joined peers such as Conagra Brands and General Mills in removing artificial food colors from their products.

Conagra Brands said on Wednesday it would remove synthetic colors from its U.S. frozen products by the end of this year and would stop selling products with artificial colors to K-12 schools by 2026-2027.

Earlier this month, General Mills announced plans to remove artificial colors from its entire U.S. retail business, including cereals and foods served in K-12 schools, by the summer of 2026.

Kraft Heinz has also said it would stop launching new products containing artificial colors in the United States and plans to eliminate synthetic dyes from existing items by the end of 2027.

spot_img

Explore more

spot_img

Scientists Warn: Long Work Hours May Physically Alter Your Brain

Scientists Warn: Long Work Hours May Physically Alter Your Brain Overwork can lead to neuroadaptive changes that impair cognitive and emotional health. Working long hours may...

China’s Sciwind’s GLP-1 shows similar weight loss to Novo’s Wegovy, study...

China's Sciwind's GLP-1 shows similar weight loss to Novo's Wegovy, study finds Overweight patients given an experimental weight loss drug being developed by China's Sciwind...

Lilly to launch Mounjaro pen in India to compete with Novo’s...

Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy India's drug regulator on Thursday approved the launch of pre-filled injector...

Novo Nordisk’s experimental drug results in up to 24% weight loss

Novo Nordisk's experimental drug results in up to 24% weight loss Novo Nordisk on Friday said full results from early-stage trials show that its experimental...

US to stop financial support of global vaccine alliance Gavi, health...

US to stop financial support of global vaccine alliance Gavi, health secretary says The U.S. will no longer contribute funding to Gavi, a global alliance...

Pfizer’s bleeding disorder therapy succeeds in trial with patients with certain...

Pfizer's bleeding disorder therapy succeeds in trial with patients with certain antibodies Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in...

Nektar’s lead drug candidate shows promise in eczema trial, shares soar

Nektar's lead drug candidate shows promise in eczema trial, shares soar  Nektar Therapeutics (NKTR.O), opens new tab said on Tuesday its lead drug candidate met the main...

US FDA approves Gilead’s twice-yearly injection for HIV prevention

US FDA approves Gilead's twice-yearly injection for HIV prevention The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences (GILD.O), opens new tab lenacapavir, a twice-yearly...